Health knowledge made personal
|
ConjuGon Inc. has raised $1.9 million in equity to develop drugs that combat bacterial infections, according to a Securities and Exchange Commission filing. These funds come from three investors and are part of an offering that is expected to bring in a total of $4.75 million.
|
Write a comment:
|
